Introduction
============

Conversion of lignocellulosic biomass into fuels and chemicals is an attractive, sustainable alternative to traditional petroleum refining \[[@B1]\]. Accomplishing this goal using fungal or microbial hosts requires optimized cellular systems \[[@B2]\]. Since its inception, metabolic engineering has served as an effective platform approach to optimize and control small molecule production in cells \[[@B3]-[@B8]\]. Moreover, recent developments in genetic approaches have advanced the metabolic engineering toolbox beyond overexpression and knockout techniques \[[@B9]-[@B13]\]. This progress is evinced by the wide variety of secondary metabolite and novel products engineered for production in cells \[[@B14]-[@B21]\]. It is anticipated that metabolic engineering approaches can help solve the challenges of biofuel production \[[@B22]-[@B24]\]. However, these approaches have all traditionally focused on rerouting cellular metabolism using standard native sugars as carbon sources.

Lignocellulosic biomass presents new challenges for the metabolic engineering paradigm \[[@B25],[@B26]\]. Although biomass is chiefly composed of glucose, the pentose sugars D-xylose and L-arabinose can also constitute significant fractions (up to 20%) that must be converted \[[@B27]\]. Even though many organisms are capable of natively converting these sugars, the most commonly selected organism is baker\'s yeast (*Saccharomyces cerevisiae*). The genetic tractability, widespread industrial use and endogenous ethanol production capacity of yeast motivate its use \[[@B28]\]; however, baker\'s yeast must be engineered to convert xylose and arabinose. Traditional pathway engineering approaches have enabled xylose and arabinose catabolism in yeast, but continued optimization of these strains requires novel metabolic engineering tools and strategies. Specifically, novel approaches should target and exploit additional cellular mechanisms influencing metabolic pathways, such as molecular transport, catabolite sensing and cellular tolerances.

In this review, we propose simultaneous transport and metabolic engineering, including new global cellular metabolic engineering techniques, as a powerful approach for the development of an economical hexose and pentose cofermenting yeast. As this review will illustrate, molecular transport and metabolic pathway engineering have conventionally been studied in isolation despite their intricate interdependence. To efficiently arrive at an optimized strain, metabolic engineering tools must be expanded to modify multiple interdependent steps, an approach we term \'panmetabolic engineering\'. Metabolic engineering tools must also expand to incorporate recent breakthroughs in modifying catabolite sensing and in increasing cellular tolerances to significantly affect biofuel-producing organisms. Once developed, these tools will enable the addition of other substrates to the yeast carbon source portfolio. Therefore, the scope of this review is to discuss recent literature concerning pentose transport and metabolism in yeast, and to suggest a path forward for engineering nonnative carbon source metabolism in organisms.

Engineering exogenous pentose sugar utilization in yeast
--------------------------------------------------------

### Pathway assembly by heterologous gene expression

Baker\'s yeast is an ideal industrial fermentation host; however, it possesses little to no xylose or arabinose metabolic capability. Interestingly, the *S. cerevisiae*genome is encoded with a putative xylose metabolic pathway, although the expression level of these genes are often too low to permit growth on xylose as the sole carbon source \[[@B29]-[@B31]\]. Recent work suggests that some strains of *Saccharomyces*may possess a latent oxidoreductase pathway with an active xylitol dehydrogenase \[[@B32]\]. However, this pathway was shown to be repressed by other putative xylitol dehydrogenases, illustrating unique and potentially *trans*-acting control mechanisms. Even so, yeast lack effective xylose and arabinose utilization pathways, and therefore require heterologous complementation or significant genetic modification.

The advent of recombinant DNA technology enabled the transfer of genes from native pentose catabolizing organisms into baker\'s yeast, thus facilitating novel pentose catabolism \[[@B33]-[@B36]\]. Two types of pentose pathways have been constructed in yeast: the oxidoreductase pathway and the isomerase pathway (Figure [1](#F1){ref-type="fig"}). Both xylose and arabinose can be metabolized through each of these pathways, although arabinose assimilation involves additional steps in both cases \[[@B37]\]. All four possible pathway variants have been previously constructed \[[@B37]-[@B40]\], and all feed into native yeast metabolism via D-xylulose or D-xylulose-5-phosphate (P). Once converted to xylulose 5-P, these sugars are further metabolized through the native pentose phosphate pathway (PPP). The following sections give a brief review of these pathways. Combined with molecular transporter engineering, they form the foundation of the panmetabolic engineering described in more detail later.

![**Successful exogenous transport and metabolic pathways introduced in *S. cerevisiae***. Reported improvements of pentose utilization in yeast (as described in the text) are depicted in this schematic. **(A)**Bacterial xylose isomerase pathway; **(B)**fungal xylose oxidoreductase pathway; **(C)**Fungal arabinose oxidoreductase pathway; **(D)**Bacterial arabinose isomerase pathway. The genes used to accomplish the enzymatic step are italicized. Heterologous steps are indicated by dashed lines.](1754-6834-3-24-1){#F1}

### Oxidoreductase pathways

The pentose oxidoreductase pathways are conserved between certain species of native fungi, and employ common enzymes and redox cofactors to catalyze substrate conversion. The xylose oxidoreductase pathway was the first heterologous pentose pathway constructed in baker\'s yeast \[[@B38]\]. In this pathway, depicted in Figure [1](#F1){ref-type="fig"}, xylose is reduced to xylitol by an aldose reductase (AR), then xylitol is oxidized to xylulose by xylitol dehydrogenase (XDH). The AR most commonly used is encoded by *Pichia stipitisXYL1*(xylose reductase, XR) which prefers the cofactor NADPH over NADH. The XDH is encoded by *P. stipitisXYL2*, which is NAD^+^dependent \[[@B41]\].

The L-arabinose oxidoreductase pathway was also the first variant constructed in baker\'s yeast for arabinose conversion \[[@B42]\]. Figure [1](#F1){ref-type="fig"} illustrates that the two enzymes from the xylose oxidoreductase pathway AR and XDH serve as catalysts of the first and last reactions, respectively. The remaining two steps have recently been constructed using two genes from the fungus *Trichoderma reesei*(*Hypocrea jecorina*). The first gene, *lad1*, encodes an arabitol 4-dehydrogenase (ADH) which reduces arabitol to L-xylulose using NADPH as a cofactor \[[@B43]\]. The second is an L-xylulose reductase (XR) encoded by *lxr1*, which reduces L-xylulose to D-xylulose using NAD^+^as a cofactor \[[@B42]\].

The D-xylulose from both the xylose and arabinose variants is then utilized by native metabolic steps, culminating in the production of biomass, carbon dioxide and ethanol.

It is important to recognize the cofactor imbalances of the arabinose and xylose oxidoreductase pathways. This imbalance is thought to limit theoretical and actual pentose conversion by yeast \[[@B25],[@B44]\]. Whereas the enzymes discussed above alone are sufficient to enable xylose or arabinose metabolism in yeast, the xylulokinase gene from *P. stipitis*(*XYL3*) is often complemented to create a complete heterologous pathway and further reduce xylitol production \[[@B28],[@B45],[@B46]\].

### Isomerase pathways

In contrast to the pentose oxidoreductase pathway, the isomerase pathway variants require no cofactors. The pathway is native to bacterial species and to rare yeasts. The heterologous xylose isomerase pathway minimally consists of one enzyme, xylose isomerase (XI), which directly converts xylose to xylulose (Figure [1](#F1){ref-type="fig"}). Because most XIs are native to bacteria, difficulties for heterologous expression in yeast exist \[[@B47]\], yet recent work has demonstrated functional bacterial XI pathways \[[@B39],[@B48]\]. In addition, bioprospecting has yielded functional heterologous XIs isolated from rare fungi \[[@B49],[@B50]\]. As with the oxidoreductase pathway, the complementation of a xylulokinase can further improve yields and assimilation rates. This pathway has improved ethanol conversion yields over the oxidoreductase pathway; however, strains have lower growth rates and sugar uptake rates, as discussed later. Nevertheless, this pathway is attractive because of its lack of cofactor imbalance.

Whereas the xylose isomerase pathway involves one step, the arabinose isomerase pathway consists of three. First, an arabinose isomerase encoded by *araA*converts arabinose to ribulose. Second, a ribulokinase encoded by *araB*phosphorylates ribulose to ribulose 5-P. Third, ribulose-5-P-4-epimerase, encoded by *araD*, catalyzes the final epimerization of ribulose 5-P to D-xylulose-5-P, an intermediate in the PPP. Two variations of this pathway have been constructed in yeast using distinct sets of heterologous genes. The first set uses *Bacillus subtilis araA*along with *Escherichia coli araB*and *araD*\[[@B40]\]. The second relies on the expression of *Lactobacillus plantarum araA, araB*and *araD*\[[@B51]\]. However, unlike the other pathways described above, evolutionary engineering was needed in both cases to isolate a yeast strain with an active arabinose isomerase pathway. Thus, only after mutations is a functional arabinose isomerase pathway in yeast possible.

### Optimization of limiting steps

The work described above establishes viable pentose utilization pathways in baker\'s yeast, enabling xylose and arabinose to be used as a sole carbon source. However, reported growth rates remain suboptimal for economical production of biofuels from lignocellulosic biomass \[[@B2]\]. This limitation has driven further improvements of the heterologous pathways by both traditional metabolic engineering approaches and heterologous molecular transporter expression.

The following sections review individual efforts to improve internal pathways and transport in yeast. Through this work, limiting steps have been identified and partially alleviated. However, pathway optimization and transporter engineering in isolation has not yet produced an optimal organism. An approach integrating both pathway and transport engineering may produce more industrially viable results.

### Internal pathway

When the xylose oxidoreductase pathway is expressed in *S. cerevisiae*, several factors limit ethanol production, with the primary one being cofactor imbalance. XR has a higher specificity for NADPH than for NADH (K~m~= 3.2 μmol/l for NADPH and K~m~= 40 μmol/l for NADH) and XDH uses only NAD^+^. In yeast, there is a disparity between the amount and accessibility of intracellular NADPH and NADH for the xylose pathway enzymes \[[@B52],[@B53]\]. This disparity could be due to competition for NAD+ by other endogenous metabolic enzymes or to inefficient xylose pathway enzymes. As a result, high amounts of xylitol may be produced \[[@B41]\]. A severe cofactor imbalance (with two NADPH and two NAD^+^required) limits the arabinose oxidoreductase pathway \[[@B54]\]. As a result, this pathway exhibits poor cell growth or little ethanol production, even though the enzymes are actively expressed \[[@B36],[@B54]\].

Modifying the affinity or expression level of XR and XDH in the xylose oxidoreductase pathway has been shown to decrease xylitol production and increase ethanol yield \[[@B37],[@B55]-[@B57]\]. However, even with adjusting cofactor preferences, a significant increase in ethanol production has not been achieved \[[@B25],[@B56]\]. Xylitol formation may not be solely a consequence of inappropriate redox balance; some additional metabolic factors in the host may cause its production. Supporting this hypothesis, native *P. stipitis*does not produce significant amounts of xylitol, whereas recombinant *S. cerevisiae*expressing the same genes produces abundant xylitol \[[@B53]\]. Xylitol is still seen in strains expressing a complete *XYL1/2/3*pathway from *P. stipitis*. Therefore, balancing mechanisms eliminating excess xylitol in *P. stipitis*may not be present in baker\'s yeast.

In the xylose isomerase pathway, xylose is converted to xylulose through a one step enzyme reaction catalyzed by xylose isomerase \[[@B41]\]. In this redox-neutral process, cofactor imbalance is avoided, no xylitol is produced, and the ethanol yield is much higher than in the oxidoreductase pathway \[[@B25],[@B49],[@B50]\]. However, strains expressing xylose isomerase have low anaerobic xylose consumption and growth rates due to insufficient activity of the heterologous xylose isomerase \[[@B35],[@B46],[@B50],[@B53],[@B58]\]. Moreover, at equilibrium, the isomerization reaction is more favorable for xylose than xylulose formation (ratio of 80:20) \[[@B59],[@B60]\]. Beyond genetic approaches, the equilibrium of the xylose isomerase reaction can be shifted to favor xylulose formation by supplementing with chemicals such as borate \[[@B61]\].

These facts emphasize the need for either increased bioprospecting for more active xylose isomerases or protein engineering to improve performance in yeast. Optimizing expression is also important, and coregulating a xylose isomerase with downstream enzymes may prove effective. Because the xylose isomerase pathway has only recently been engineered in *S. cerevisiae*, an improved xylose isomerase with satisfactory activity may still be discovered or engineered.

Consistent with the xylose isomerase pathway, the activity of arabinose isomerase is insufficient, and the isomerization of arabinose to ribulose is unfavorable \[[@B54],[@B62]\]. In particular, insufficient cell growth and lower ethanol production rates are seen with cells grown on arabinose compared with glucose or even xylose \[[@B54]\]. Therefore, metabolic and protein engineering solutions for increasing the growth rate and shifting the driving force from aldose to ketose could improve both xylose and arabinose assimilation in recombinant *S. cerevisiae*.

Beyond the recombinant pathway steps, additional work in improving pentose utilization has focused on the native PPP. The enzymes xylulokinase (*XKS1*gene), transaldolase (*TAL1*) and transketolase (*TKL1*) have been supplemented by heterologous or overexpressed native genes. These heterologous genes have typically been imported from *P. stipitis*;, for example, *PsTAL1*may be expressed to supplement *ScTAL1*\[[@B45]\]. In the case of transaldolase, the *Pichia*version of the enzyme had more advantageous enzyme kinetics than the *Saccharomyces*version. This observation raises the possibility that additional superior PPP enzyme may exist in native xylose consumers. Bioprospecting provides a means of identifying such enzymes.

Taken together, metabolic engineering has been able to construct and improve the pentose utilization pathways in yeast. However, these improvements have yet to produce a strain that allows widespread lignocellulosic biomass conversion to biofuels. Explanations may include host genotype fitness; for example, the putative xylitol dehydrogenases may actually be detrimental to xylose metabolism \[[@B32],[@B45]\]. These and other potential regulatory mechanisms such as protein acetylation patterns or other unknown regulatory factors may be inhibiting pentose utilization \[[@B63]\]. Therefore, more targets and studies are required to advance the field. One of the unique primary targets being examined is the optimization of pentose transport in yeasts.

### Transport

Sugar transport across the membrane does not significantly limit the endogenous metabolism of sugars such as glucose, although it may limit exogenous pentose metabolism. Without any genetic modifications, baker\'s yeast will transport pentoses across the cell membrane through one of many native hexose transport proteins: the *S. cerevisiae*proteins Hxt7p, Hxt5p, Hxt4p, Hxt2p, Hxt1p and Gal2p \[[@B40],[@B64]-[@B66]\]. However, these proteins have a much higher affinity for their native hexose substrates, which may create unfavorable competitive inhibition and lead to diauxic growth in a hexose-pentose cofermentation. Therefore, dedicated pentose transport provides an opportunity to improve the simultaneous use of hexoses and pentoses.

It has been demonstrated or inferred in several cases that pentose transport accounts for significant pathway flux control \[[@B67]-[@B69]\]. Gardonyi *et al.*reported a flux control coefficient of 0.2 for xylose transport in *S. cerevisiae*TMB 3001 (CEN.PK-2 XR/XDH/XKS) regardless of xylose concentration, and rising to 0.5 in *S. cerevisiae*TMB 3206 (TMB 3001 with overexpressed XR) at xylose concentrations below 0.6 g/l \[[@B67]\]. Recently, an evolutionary engineering experiment (aided by continuous culturing in xylose) was performed using an optimized *S. cerevisiae*strain overexpressing six key xylose metabolic enzymes (including XI, XKS, TAL and TKL) \[[@B68]\]. Accumulated mutations over time resulted in greatly altered xylose transport kinetics, doubling V~max~(15.8 to 32 mmol per dry weight per hour) and reducing K~m~by 25% (132 to 99 mmol/lM). From this result, it may be inferred that xylose transport is a limiting step, especially in metabolically optimized strains with higher downstream flux capacity. An additional evolutionary engineering experiment with recombinant *S. cerevisiae*found an increase in expression of the hexose transporter gene *HXT5*\[[@B69]\], showing that cells choose to increase transport activity when selected on xylose. In terms of L-arabinose transport, it has been demonstrated that the native hexose transporter gene *GAL2*is essential for pathway function \[[@B40]\], thus implicating the lack of a specific arabinose transporter protein.

The above findings underpin recent work focusing on heterologous transporter protein identification and expression to improve xylose uptake. Heterologous transport proteins from plant, bacteria and other yeasts have been cloned and expressed in recombinant *S. cerevisiae.*However, only the class of transporters native to yeast, the major facilitator superfamily (MFS) \[[@B70]\], has been investigated. Other classes, such as the ATP binding cassette (ABC) transporters and the bacterial phosphoenolpyruvate (PEP) dependent transporters, are unlikely to be effective, because of expression difficulty and high relative energy requirements \[[@B71]\]. Despite ongoing work and bioprospecting, researchers have been unable to isolate or evolve a transport protein with xylose as its highest affinity substrate. Such a transporter would greatly enhance the prospects of a glucose-xylose cofermentation.

The collective results from heterologous pentose transporter expression studies are summarized in Table [1](#T1){ref-type="table"}. To date, no heterologous arabinose transport experiments have been conducted, in part because of the recent reconstruction of an arabinose metabolic pathway in yeast. The most successful improvement of xylose transport to date is the expression of *Candida intermedia*PYCC 4715 transport proteins \[[@B72]\]. Both *C. intermedia GXF1*and *GXS1*conferred significant improved growth phenotypes in recombinant *S. cerevisiae*when glucose and xylose were used as sole carbon sources. Subsequent work has evaluated coexpression of the two proteins \[[@B73]\] as well as more in-depth fermentation analysis \[[@B74]\]. Both of these transporters are efficient xylose transporters, yet also have a high affinity for glucose. Therefore, they remain primarily hexose transporters, despite the excellent xylose transport characteristics.

###### 

Transport proteins studied for xylose uptake.

  Genus             Species        Gene or DNA Library           UniProt   Plasmid     Study         Strain    Xylose transport phenotype
  ----------------- -------------- ----------------------------- --------- ----------- ------------- --------- ----------------------------
  *Arabidopsis*     *thaliana*     Stp2                          Q9LNV3    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Arabidopsis*     *thaliana*     Stp3                          Q8L7R8    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Arabidopsis*     *thaliana*     At5g59250                     Q0WWW9    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Arabidopsis*     *thaliana*     At5g59250                     Q0WWW9    pRH145      \[[@B75]\]    BY4727    \+
                                                                                                               
  *Arabidopsis*     *thaliana*     At5g17010                     Q6AWX0    pRH145      \[[@B75]\]    BY4727    \+
                                                                                                               
  *Arabidopsis*     *thaliana*     Seedling cDNA \[[@B104]\]     \-        pFL61       \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Candida*         *intermedia*   Gxf1                          Q2MDH1    YEplac195   \[[@B72]\]    TMB3201   \+
                                                                                                               
  *Candida*         *intermedia*   Gxs1                          Q2MEV7    YEplac195   \[[@B72]\]    TMB3201   \+
                                                                                                               
  *Chlorella*       *kessleri*     Hup1                          P15686    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Escherichia*     *coli*         XylE                          P0AGF4    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Pichia*          *stipitis*     SUT1                          O94155    YEp24       \[[@B105]\]   RE700     \-
                                                                                                               
  *Pichia*          *stipitis*     SUT2                          O94151    YEp24       \[[@B105]\]   RE700     \-
                                                                                                               
  *Pichia*          *stipitis*     SUT3                          Q9UWF5    YEp24       \[[@B105]\]   RE700     \-
                                                                                                               
  *Pichia*          *stipitis*     Genomic library \[[@B105]\]   \-        YEp24       \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Trichoderma*     *reesei*       Xlt1                          Q1EG32    pAJ401      \[[@B66]\]    H2219     +\*
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT1                          P32465    pYX212      \[[@B66]\]    H2219     \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT2                          P23585    pYX212      \[[@B66]\]    H2219     \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT4                          P32467    pYX212      \[[@B66]\]    H2219     \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT7                          P39004    pYX212      \[[@B66]\]    H2219     \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT1                          P32465    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT3                          P32466    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT4                          P32467    p4H7        \[[@B64]\]    TMB3201   \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT5                          P38695    p4H7        \[[@B64]\]    TMB3201   \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT7                          P39004    YEpkHXT7    \[[@B64]\]    TMB3201   \+
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT8                          P40886    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT9                          P40885    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT10                         P43581    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT11                         P54862    p426MET25   \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT13                         P39924    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT14                         P42833    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   HXT15                         P54854    p4H7        \[[@B64]\]    TMB3201   \-
                                                                                                               
  *Saccharomyces*   *cerevisiae*   GAL2                          P13181    pHL125      \[[@B64]\]    TMB3201   \+

Several previous studies have evaluated the capacity of selected transport proteins to uptake xylose in yeast.

The strain genotype (described in Table 2) used and the identified xylose phenotype is listed.

\*Indicates that mutations (either in the gene or in the host cell) were required for the phenotype to appear.

Heterologous xylose transport phenotypes were observed in yeast expressing *A. thaliana At5g59250*and *At5g17010*\[[@B75]\]. However, this observation was not supported by a second study in which *At5g59250*expression did not confer growth on xylose \[[@B64]\]. These studies, as Table [2](#T2){ref-type="table"} clarifies, did not use the same host strain. In the first study with *At5g59250*, a standard strain of yeast was used whereas in the second, a strain lacking the HXT family of proteins was used. Interactions between membrane proteins, such as those demonstrated above with *GXF1*and *GXS1*\[[@B73]\], may explain this discrepancy. In this regard, the *A. thaliana*proteins may potentially act as sensors or activators of HXT family transporters. These results illustrate the importance of genotype on transporter characterization studies. Moreover, they emphasize the need for simultaneous optimization of both transport processes and metabolic pathways.

###### 

Various host strains used to analyze transporter function.

  Strain    Relevant genotype                                              Other plasmids (promoter and gene)
  --------- -------------------------------------------------------------- --------------------------------------------------------
  TMB3201   Δhxt1-17 Δgal2 Δstl1 Δagt1 Δmph2 Δmph3 his3-Δ1::YIpXR/XDH/XK   \-
                                                                           
  BY4727    MATα his3Δ200 leu2Δ0 lys2Δ0 met15Δ0 trp1Δ63 ura3Δ0             P~ADH1~-PsXYL2, P~PGK1~-PsXYL1, P~HXT7~-ScXKS1-T~HXT7~
                                                                           
  H2219     Δhxt1-7 Δgal2 ura3-Δ1::XR/XDH his3-Δ1::XK                      \-
                                                                           
  RE700     Δhxt1-7                                                        \-

The basic genotype of strains used in prior transporter assay studies is provided.

Importantly, research has been unable to experimentally identify the highly efficient pentose transport system of *P. stipitis*, even though it is the source organism for many pentose metabolic genes. Specifically, a *P. stipitis*genomic DNA library transformed into a transporter-null strain of *S. cerevisiae*yielded no transformants able to grow on xylose \[[@B64]\]. Further investigation is needed because *P. stipitis*is known to have an excellent xylose transport system, yet to date no high-affinity xylose transporters have been isolated. The recently published genome sequence of this organism will certainly aid future research in this area \[[@B76]\], although most transporter proteins in the genome are currently annotated by homology and have not been characterized.

All of these studies make up a large body of work concerning heterologous transport protein expression in *S. cerevisiae*, and motivate further exploration for dedicated xylose transporters. However, future studies in this area must proceed with caution. Owing to the native transport characteristics of yeast, efficient transporters may need to be discovered through the use HXT family knockout strains \[[@B77]\]. It is also unknown how transporter proteins interact with each other to produce certain phenotypes. Specifically, *P. stipitis*xylose transport may involve transporter cooperation to achieve a high rate of xylose influx. Evidence of such transporter cooperation has already been demonstrated when coexpressing *C. intermedia GXS1*and *GXF1*\[[@B73]\]. Additionally, many transmembrane proteins act as sensors; for example, *RGT2*and can control transporter expression \[[@B78]\]. Furthermore, the internal xylose catabolism pathway used in conjunction with heterologous or engineered xylose transporters can determine the level of flux control exhibited by the transport step \[[@B67]\]. Naturally, as the internal metabolic pathway is improved, pentose transport will become a greater limitation. Therefore, novel tools and approaches must accomplish simultaneous optimization of transport and metabolism - the tools and approaches of panmetabolic engineering.

Panmetabolic engineering: the path forward for pentose utilization in yeast
---------------------------------------------------------------------------

As demonstrated above, pathway and transport optimization strategies have had little crossover. Pathway optimization targets were shown to have moved beyond merely expressing initial pathway genes to include those encoding proteins in the pentose phosphate pathway. These modifications greatly improved xylose assimilation and fermentation rates, yet, the most advanced strains used in the transporter expression studies (TMB3201 and H2219) only contained simple complementation of the three-enzyme xylose oxidoreductase pathway. We propose that this dichotomy exists because pathway-engineering approaches begin with the assumption that internal cellular pathways limit maximum production rates. As a result, approaches focus on importing heterologous pathways, and subsequently removing intracellular flux bottlenecks by replacing low capacity enzymes with overexpressed or optimized versions \[[@B28],[@B79]\]. Despite this, strains with these improvements still exhibit suboptimal growth rates on xylose and arabinose \[[@B45],[@B51]\]. Regardless, these strictly intracellular pathway engineering approaches will fail when the assumption is incorrect; that is, when molecular transport limits maximum production rates. This premise is the motivation for heterologous transporter expression. However, the vast majority of transporter studies have only investigated how to obtain improved transport through heterologous transporter expression; pathway fitness is generally not considered. From these points of view, the inter-related problems of pathway inadequacy and transport limitation have been studied in isolation. Therefore, to achieve the optimal biofuel-producing cell, novel pathway engineering and molecular transport engineering approaches must be combined and simultaneously optimized.

Therefore, the field seems poised for a new development: panmetabolic engineering. In this paradigm, the transport and pathway steps comprising the whole utilization pathway will be optimized concurrently, and may result in leaps forward in biofuel production from lignocellulosic biomass. In this regard, the expression and activity profiles across the entire pathway will be coordinated for maximal flux.

To implement panmetabolic engineering, new tools will be necessary. These tools must be able to simultaneously evaluate the effectiveness of individual mutant proteins while balancing the expression of transporters and multiple pathway genes. At the moment, nearly all protein and metabolic engineering strategies proceed in a stepwise manner to improve pathways. A recent example of complex, multistep pathway optimization is seen with improving levopimaradiene production in *E. coli*\[[@B80]\]. As a result, high-throughput methods involving combinatorial engineering of transporters and downstream enzymes are necessary to accelerate pathway improvement. One such approach could be achieved by adapting existing tools such as DNA assembler \[[@B10]\]. This tool takes advantage of yeast homologous recombination to build multiplex gene assembly and plasmid construction without restriction enzyme cloning, and can be used to randomize genes and promoters. Thus, mixtures of transporter and pathway enzyme mutants along with expression elements could be transformed into yeast to allow for simultaneous gene and expression level selection. Other approaches are certainly possible, and will largely be informed by the ever-increasing list of combinatorial pathway modification strategies \[[@B81]\]. Particular challenges with such approaches include search space reduction and improved selection strategies.

Bioinformatic tools can help pre-select (or potentially, may one day design *de novo*) enzymes of interest for the desired pathway. Protein structural information can help limit search spaces for directed evolution or rational design strategies. Resources such as the Basic Local Alignment Search Tool (BLAST) draw upon the success of genomic sequencing projects \[[@B76],[@B82]\], allowing access to the extant biodiversity in other organisms. An example of the power of structural information and homology was shown in the recent engineering of levopimaradiene synthase \[[@B80]\]. By combining protein engineering with upstream pathway modifications, a 2,600-fold increase in levopimaradiene production was observed \[[@B80]\]. In terms of pentose utilization, enzyme sequence homology among organisms was used to assemble the *L. plantarum*arabinose pathway in yeast \[[@B51]\], to discover a functional heterologous bacterial XI \[[@B48]\], and to find likely candidates for pentose transport capability. Increasing sequence information from organisms relevant to lignocellulosic biomass utilization (including organism such as *P. stipitis*and *T. reesei)*can advance the panmetabolic engineering approach by providing more diversity of starting pathway proteins.

However, a high-throughput method will eventually be necessary to experimentally validate the functions of sequenced genes. Screening strategies (often employed to enable directed evolution) may be useful, but a high-throughput genotype to phenotype mapping method such as multiscale analysis of library enrichment (SCALEs) \[[@B83]\] may work best. With this approach, individual enzymes or whole operons that confer beneficial phenotypes may be discovered. With advancements in microarray technology, an adapted form of SCALEs could be used to screen a genomic library in yeast for transporter, pathway and regulatory enzymes. Such an approach could identify novel enzymes that confer beneficial phenotypes but do not yet have an annotated \'relative\' and therefore are not identifiable using *in silico*search strategies such as BLAST. High-throughput phenotyping and analysis will not only be useful for bioprospecting efforts, but for screening the large libraries created from the large-scale combinatorial techniques mentioned above.

Classic strain engineering methods such as evolutionary engineering have been, and will probably continue to be, effective in bringing about efficient pentose metabolism in *S. cerevisiae.*Thus, the role of evolutionary engineering combined with panmetabolic engineering must be considered. Evolutionary engineering has been intensively used in industry for obtaining microorganisms with desired properties, such as efficient utilization of substrate and higher product tolerance \[[@B84]\]. Recently, evolutionary adaptation of engineered *S. cerevisiae*showed significant improvements in growth rate, utilization of pentose sugars and ethanol production \[[@B61],[@B68],[@B85]-[@B88]\]. However, this process should be directed and accelerated to more robustly harness the power of natural selection to evolve *S. cerevisiae*strains with the desired properties for ethanol production from lignocellulosic biomass. Additionally, advances in high-throughput genome sequencing and detection of single nucleotide polymorphisms have begun to enable the resequencing of evolved strains. Such capability would speed the development of rational techniques for strain improvement by enabling a link between genotype and phenotype. Already, combining the power of evolution with rational bioinformatics and systems biology has produced iterative strain engineering \[[@B89]\]. As these techniques develop, combining evolutionary engineering with pathway construction can further increase yields and efficiencies. However, computational paradigms will be necessary to draw the complete link between mutant genome sequence and functional phenotype.

Directed evolution of proteins has been used for redesigning and optimizing target enzymes and has obtained significant improvements in stability, tolerance, substrate specificity and product selectivity \[[@B90]\], although this technique has been underused in engineering transmembrane proteins \[[@B91]\]. For successful biofuel production with pentose sugars, directed evolution could be used at several points in the pentose assimilation process: for optimizing enzyme properties (such as higher activity of XI, low selectivity of XR to NADPH and optimal activity of XKS), for increasing transporter specificity towards xylose and arabinose, and for improving tolerance to ethanol. By combining directed evolution with more global evolutionary engineering strategies, it may be possible to simultaneously co-evolve multiple proteins in this process. Thus, this vision of panmetabolic engineering would prove powerful for improving metabolic flux in the context of lignocellulosic biomass utilization.

Global cellular tools for improving non-pathway based phenotypes
----------------------------------------------------------------

Global approaches emerging from synthetic and systems biology may also have a role in improving pentose pathways \[[@B92]\]. Particularly, enhanced understanding of cellular signaling and synthetic circuitry could play a large role in optimization of pentose utilization. Lessons can be learned from other successful metabolic synthetic biology projects \[[@B93]\], yet the singular problem of exogenous sugar utilization will necessitate panmetabolic engineering along with global, synthetic cellular engineering.

Catabolite sensing may limit pentose metabolism, although mechanisms could be optimized to improve the fermentation characteristics of modified yeasts. Initial work has begun on understanding the regulatory effects of heterologous pathway expression \[[@B78]\], but further investigation must be undertaken. Glucose sensing and repression plays a large role in the metabolic response of yeast \[[@B94]-[@B98]\], including regulation of the hexokinase *HXK2*in response to glucose \[[@B99]\]. Additionally, the yeast hexose transporters are subject to glucose regulation through a variety of mechanisms \[[@B100]\]. Furthermore, recent discoveries point to additional regulatory mechanisms triggered by glucose, such as cytosolic pH, influencing global cellular metabolic phenotypes \[[@B101]\]. Finally, transmembrane sensor proteins are thought to initiate several responses to extracellular metabolites. In many cases, these are major facilitator superfamily proteins with strong similarity to transport-capable transmembrane proteins. Future work must investigate the differences between a sensor and a transporter.

All of these regulatory mechanisms may play a role in the diauxic growth phenotype exhibited when yeast are presented with two carbon sources. Indeed, glucose-activated repression of the PPP may contribute to the low flux phenotypes observed in hexose and pentose cofermentations \[[@B78]\]. Optimization of this regulatory network must take place for panmetabolic engineering to succeed. For direction, reprogramming motility and toxin degradation in bacteria \[[@B102]\] demonstrates the feasibility of regulatory reprogramming, which may permit more efficient hexose and pentose consumption.

In addition to catabolite sensing and response, other global cellular phenotypes such as product tolerance have a large influence on the success of the fermentation. Importantly, improving cellular tolerances is possible, although underused \[[@B103]\]. In both of these applications, next generation metabolic engineering approaches such as global transcription machinery engineering (gTME) \[[@B103]\] may be able to alter global characteristics of *S. cerevisiae*. Without relying on *a priori*knowledge, gTME applies the success of directed evolution strategies to transcription factors. The major premise of this approach is that introducing dominant mutant alleles of generic transcription-related proteins can reprogram gene networks and cellular metabolism. In particular, key transcription factors (such as the TATA binding protein in yeast) are mutated to create diverse libraries. These mutants are selected on the basis of their ability to improve cellular phenotypes. By doing so, it is possible to alter complex phenotypes such as ethanol tolerance in yeast \[[@B103]\]. Using this method, transcription factors may also be engineered to optimize cellular systems for improved pentose fermentation characteristics, because the metabolism of sugars is tightly regulated \[[@B96],[@B98]\]. This approach has the ability to improve several of the phenotypes related to pentose utilization, including high sugar tolerance and regulatory issues. Collectively, whole cell approaches may integrate the utilization pathway more fully into the host, and may alleviate difficulties such as cofactor imbalances and regulation.

Conclusion
==========

Metabolic engineering approaches must be adapted to address the challenges for pathway and global cellular optimization that currently limit the construction of an integrated, efficient pentose pathway. Although much progress has indeed been made in the past 20 years towards lignocellulosic biomass conversion by yeasts, the iterative approach of identifying limiting steps, optimizing and identifying limiting steps, *ad infinitum*, must accelerate. More emphasis on host genome and regulatory structure must occur in future projects to understand the full effect of biological complexity on a pathway. In this regard, classic approaches combined with next-generation technologies may be combined to allow simultaneous optimization of all steps in a pathway. The idealized approach combines the power of many approaches including pathway engineering, directed evolution, evolutionary engineering, and combinatorial genetics to harness this cellular complexity. To date, many of these approaches have been performed in isolation for creating pentose-utilizing yeast. In summary, the field stands ready for the paradigm shift to panmetabolic engineering, necessarily including novel global cellular engineering tools.
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